IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: Relationship with the severity of the disease

Transfusion

Volumn 42, Issue 12, 2002, Pages 1537-1546

  Lambin, Patrick ^a,b   Debbia, Martine ^a,b   Puillandre, Philippe ^a,b   Brossard, Yves ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Center for Perinatal Hemo biology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; RHESUS D ANTIBODY;

ADULT; ARTICLE; BLOOD; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INTRAUTERINE BLOOD TRANSFUSION; MOTHER; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY;

ADULT; BLOOD TRANSFUSION, INTRAUTERINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INFANT, NEWBORN; MOTHERS; PREGNANCY; RHO(D) IMMUNE GLOBULIN; SEVERITY OF ILLNESS INDEX;

EID: 0036887201     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00239.x     Document Type: Article

References (32)

1. 1 Leach JL, Sedmak DD, Osborne JM, et al. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal‐fetal antibody transport. J Immunol 1996 ; 157: 3317 ‐ 22.
2. 2 Bowman JM. Alloimmune hemolytic disease of the fetus and newborn. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, editors. Wintrobe's clinical hematology. 10th eds. Baltimore: Williams & Wilkins ; 1999: 1210 ‐ 32.
3. 3 Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000 ; 14: 44 ‐ 61.
4. 4 Urbaniak SJ. Consensus conference on anti‐D prophylaxis, April 7 and 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetrician and Gynaecologists. Transfusion 1998 ; 38: 97 ‐ 9.
5. 5 Brossard Y, Parnet‐Mathieu F, Larsen M. Incompatibilit ´es foeto‐maternelles ´erythrocytaires. In: Lefŕere JJ, Rouger P, editors. Transfusion. sanguine: une approche śecuritaire. Paris: John Libbey; 2000:290‐318.
6. 6 Hadley AG. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn. Vox Sang 1998 ; 74 (Suppl. 2): 375 ‐ 83.
7. 7 Perrault R, Hogman C. Automated red cell antibody analysis: a parallel study. I. Detection and quantitation. Vox Sang 1971 ; 20: 340 ‐ 55.
8. 8 Kumpel BM. A simple non‐isotopic method for the quantitation of red cell‐bound immunoglobulin. Vox Sang 1990 ; 59: 34 ‐ 8.
9. 9 Christensson M, Bremme K, Shanwell A, Westgren M, Christensson B. Flow cytometric quantitation of serum anti‐D in pregnancy. Transfusion. 1996 ; 36: 500 ‐ 5.
10. 10 Lambin P, Ahaded A, Debbia M, Lauroua P, Rouger P. An enzyme‐linked immunosorbent assay for the quantitation of IgG anti‐D and IgG subclasses in the sera of alloimmunized patients. Transfusion. 1998 ; 38: 252 ‐ 61.
11. 11 Ahaded A, Debbia M, Beolet M, Le Pennec PY, Lambin P. Evaluation by enzyme‐linked immunosorbent assay of IgG anti‐D and IgG subclass concentrations in immunoglobulin preparations. Transfusion. 1999 ; 39: 515 ‐ 21.
12. 12 Garratty G. Factors affecting the pathogenicity of red cell auto‐ and alloantibodies. In: Nance SJ, editor. Immune destruction of red blood cells. Arlington: American Association of Blood Banks ; 1989: 109 ‐ 69.
13. 13 Mollison PL, Engelfriet CP, Contreras M. Haemolytic disease of the fetus and the newborn. In: Mollisson PL, Englefriet CP, Contreras M, editors. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell ; 1997: 390 ‐ 424.
14. 14 Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti‐Rh antibodies. Vox Sang 1987 ; 53: 96 ‐ 101.
15. 15 Kumpel BM. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti‐D. Vox Sang 1997 ; 72: 45 ‐ 51.
16. 16 Parinaud J, Blanc M, Grandjean H, et al. IgG subclasses and Gm allotypes of anti‐D antibodies during pregnancy: correlation with the gravity of the fetal disease. Am J Obstet Gynecol 1985 ; 151: 1111 ‐ 5.
17. 17 Nance SJ, Arndt PA, Garratty G, Nelson JM. Correlation of IgG subclass with the severity of hemolytic disease of the newborn (letter). Transfusion 1990 ; 30: 381 ‐ 2.
18. 18 Alie Daran SJ, Dugoujon JM, Fournie A. Gm typing, IgG subclasses of anti‐Rh (D) and severity of hemolytic disease of the newborn (letter). Vox Sang 1992 ; 62: 127 ‐ 8.
19. 19 Garner SF, Gorick BD, Lai WY, et al. Prediction of the severity of haemolytic disease of the newborn: quantitative IgG anti‐D subclass determinations explain the correlation with functional assay results. Vox Sang 1995 ; 68: 169 ‐ 76.
20. 20 Downing I, Bromilow IM, Templeton JG, Fraser RH. A retrospective study of red cell maternal antibodies by chemiluminescence. Vox Sang 1996 ; 71: 226 ‐ 32.
21. 21 Iyer YS, Kulkarni SV, Gupte SC. Distribution of IgG subtypes in maternal anti‐D sera and their prognostic value in Rh haemolytic disease of the newborn. Acta Haematol 1992 ; 88: 78 ‐ 81.
22. 22 Pollock JM, Bowman JM. Anti‐Rh (D) IgG subclasses and severity of Rh hemolytic disease of the newborn. Vox Sang 1990 ; 59: 176 ‐ 9.
23. 23 Zupanska B, Brojer E, Richards Y, et al. Serological and immunological characteristics of maternal anti‐Rh (D) antibodies in predicting the severity of haemolytic disease of the newborn. Vox Sang 1989 ; 56: 247 ‐ 53.
24. 24 Hughes‐Jones NC, Hughes MIJ, Walker M. The amount of anti‐D on red cells in haemolytic disease of the newborn. Vox Sang 1967 ; 12: 279 ‐ 85.
25. 25 Hughes‐Jones NC, Ivona M, Ellis J, Walker W. Anti‐D concentration in mother and child in haemolytic disease of newborn. Vox Sang 1971 ; 21: 135 ‐ 40.
26. 26 Gorick BD, Hughes‐Jones NC. Relative functional binding activity of IgG1 and IgG3 anti‐D in IgG preparations. Vox Sang 1991 ; 61: 251 ‐ 4.
27. 27 Shaw DR, Conley ME, Knox FJ, Khazaeli MB, LoBuglio AF. Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies. Transfusion. 1988 ; 28: 127 ‐ 31.
28. 28 Klein F, Skvaril F, Vermeeren R, Vlug A, Duimel WJ. The quantification of human IgG subclasses in reference preparations. Clin Chim Acta 1985 ; 150: 119 ‐ 27.
29. 29 Gunson HH, Bowell PJ, Kirkwood TBL. Collaborative study to recalibrate the International Reference Preparation of Anti‐D Immunoglobulin. J Clin Pathol 1980 ; 33: 249 ‐ 53.
30. 30 Economides DL, Bowell PJ, Selinger M, et al. Anti‐D concentrations in fetal and maternal serum and amniotic fluid in rhesus allo‐immunised pregnancies. Br J Obstet Gynaecol 1993 ; 100: 923 ‐ 6.
31. 31 Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996 ; 36: 248 ‐ 55.
32. 32 Engelfriet CP, Overbeeke MA, Dooren MC, Ouwehand WH, Von Dem Borne AE. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor‐induced destruction of red cells sensitized by IgG. Transfusion. 1994 ; 34: 617 ‐ 26.